The Mom & Baby Substance Exposure Initiative (MBSEI)
As part of the DHCS State Opioid Response grant program, Health Management Associates (HMA) is working to address the opioid crisis in the perinatal population by increasing access to Medication Assisted Treatment (MAT), reducing unmet treatment need, and reducing opioid overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder (OUD) and other substance use disorders (SUD) among pregnant and parenting women.
This is being accomplished through:
- Outreach, assessment and implementation work in at least 10 counties
- Developing protocols, guidelines, safety bundles, and toolkits for use by the broader health community to create a high quality approach to addressing the needs of affected mothers and infants
- Curating, developing and making available patient education materials about OUD and other SUDs
- Coordinating quality improvement collaboratives for hospital-based and other service providers to optimize in-hospital care and transitions for infants and mothers
- The provision of large-scale skill-improvement and stigma abatement training to ensure predictable practice methods
- The provision of technical assistance, and the development of a web-based library of durable training materials and resources.
HMA is working hand-in-hand with the California Maternal Quality Care Collaborative (CMQCC) and the California Perinatal Quality Care Collaborative (CPQCC) on several aspects of this initiative. Anticipated outcomes from the MBSEI include: reducing the severity and length of stay for infants with neonatal abstinence syndrome (NAS); more pregnant and parenting women initiated on MAT; increase in mothers in long term treatment and recovery; and a reduction in the unnecessary punitive involvement of child protective services.
For more information, visit the Addiction Free California website.